Trial Profile
Treatment of Childhood Nasopharyngeal Carcinoma With Neoadjuvant Chemotherapy and Concomitant Chemoradiotherapy: A Groupwide Phase III Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Oct 2022
Price :
$35
*
At a glance
- Drugs Amifostine (Primary) ; Cisplatin; Fluorouracil
- Indications Carcinoma; Nasopharyngeal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 07 Jul 2016 Status changed from active, no longer recruiting to completed, as per an abstract presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.
- 07 Jun 2016 Results at 5- year presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 03 Aug 2012 Planned end date changed from 1 Jun 2009 to 1 Dec 2014 as reported by ClinicalTrials.gov.